The Trump administration is nearing deals with drugmakers Eli Lilly and Novo Nordisk to offer some of their obesity drugs to ...
Medpage Today on MSNOpinion
The Consequences of Manufacturing Doubt in U.S. Pharmaceuticals
But last week, those words took on the force of law. On Tuesday, Texas Attorney General Ken Paxton filed a lawsuit against ...
President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how ...
Sun Pharma is open to expanding its US manufacturing capabilities in response to the Trump administration's 100% tariff on ...
Recent partnership announcements in the pharma industry reflects the community’s commitment to collaborative innovation, ...
Sun Pharma considers expanding its US manufacturing footprint amid tariffs. Focus on UNLOXCYT launch and ILUMYA filing.
The newly established division aims to produce 22mln units annually of cancer and immunosuppressive drugs that meet EU-GMP ...
Having seen Congress spend money to onshore semiconductor production, pharma groups are pushing for similar incentives for ...
Sun Pharmas CEO discusses potential expansion of its US manufacturing amid tariff challenges, focusing on localised ...
ORLANDO, FLORIDA / ACCESS Newswire / October 31, 2025 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) and NDT Pharmaceuticals Inc. (OTC:NDTP) on the RedChip ...
Cencora will invest over $1 billion through 2030 to expand its U.S. network, the drug distributor said on Wednesday, after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback